Drug Research for Neglected Diseases and Mental Health for Opioid/Substance Use Disorder (OUD/SUD) and Antiaddiction product Ibogaine in preparation for FDA Investigative New Drug Development for Opioid Abatement program in NYS. KRFI has prepared the Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga Drug Master Files IP provision for Private Public Sector Partnership for health equity, accessibility through the Clinical Trial Management Platform and drug supply chain security hyperledger.